Marcel M Verbeek
Overview
Explore the profile of Marcel M Verbeek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
250
Citations
7219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Maden M, Verbeek M, Beckers M
J Parkinsons Dis
. 2025 Feb;
:1877718X241312401.
PMID: 39973489
Parkinson's disease (PD) is a neurodegenerative disorder predominantly known for its motor symptoms such as bradykinesia, rigidity and tremor, but the disorder is also increasingly recognized for its association with...
2.
Kerstens J, Schreurs M, de Vries J, Neuteboom R, Brenner J, Crijnen Y, et al.
Neurol Neuroimmunol Neuroinflamm
. 2024 Oct;
11(6):e200318.
PMID: 39467237
Background And Objectives: Autoimmune encephalitis (AIE) and paraneoplastic neurologic syndromes (PNSs) encompass a heterogeneous group of antibody-associated disorders. Both the number of syndromes and commercially available antibody tests have increased...
3.
van den Berg E, Roelofs R, Jakel L, Greenberg S, Charidimou A, van Etten E, et al.
Ann Clin Transl Neurol
. 2024 Sep;
11(10):2563-2571.
PMID: 39268830
Objective: Elevated levels of anti-amyloid-β (anti-Aβ) autoantibodies in cerebrospinal fluid (CSF) have been proposed as a diagnostic biomarker for cerebral amyloid angiopathy-related inflammation (CAA-RI). We aimed to independently validate the...
4.
Multimodal, Longitudinal Profiling of SCA1 Identifies Predictors of Disease Severity and Progression
van Prooije T, Kapteijns K, van Asten J, IntHout J, Verbeek M, Scheenen T, et al.
Ann Neurol
. 2024 Aug;
96(4):774-787.
PMID: 39096063
Objectives: Spinocerebellar ataxia type 1 (SCA1) is a rare autosomal dominant neurodegenerative disease. Objective surrogate markers sensitive to detect changes in disease severity are needed to reduce sample sizes in...
5.
Rasing I, Voigt S, Koemans E, de Kort A, van Harten T, van Etten E, et al.
Alzheimers Res Ther
. 2024 Jul;
16(1):155.
PMID: 38971821
No abstract available.
6.
Jakel L, de Kort A, Stellingwerf A, Hernandez Utrilla C, Kersten I, Vervuurt M, et al.
Acta Neuropathol Commun
. 2024 Jun;
12(1):103.
PMID: 38915119
Cerebral amyloid angiopathy (CAA) is a highly prevalent and progressive pathology, involving amyloid-β (Aβ) deposition in the cerebral blood vessel walls. CAA is associated with an increased risk for intracerebral...
7.
de Kort A, Verbeek M, Schreuder F, Klijn C, Jakel L
J Stroke
. 2024 Jun;
26(2):179-189.
PMID: 38836267
Background And Purpose: Possible differences in the prevalence of cerebral amyloid angiopathy (CAA) in East-Asian compared to Western populations have received little attention, and results so far have been ambiguous....
8.
Jakel L, Claassen K, de Kort A, Jolink W, Vermeiren Y, Schreuder F, et al.
Brain Pathol
. 2024 May;
34(6):e13270.
PMID: 38763889
Decreased microvascular levels of claudin-5 in the occipital and temporal lobe of patients with cerebral amyloid angiopathy are associated with intracerebral haemorrhage.
9.
Vervuurt M, Kuiperij H, de Kort A, Kersten I, Klijn C, Schreuder F, et al.
Alzheimers Res Ther
. 2024 May;
16(1):108.
PMID: 38745197
Background: Sporadic cerebral amyloid angiopathy (sCAA) is a disease characterised by the progressive deposition of the amyloid beta (Aβ) in the cerebral vasculature, capable of causing a variety of symptoms,...
10.
de Kort A, Kaushik K, Kuiperij H, Jakel L, Li H, Tuladhar A, et al.
Alzheimers Res Ther
. 2024 May;
16(1):99.
PMID: 38704569
Background: Patients with sporadic cerebral amyloid angiopathy (sCAA) frequently report cognitive or neuropsychiatric symptoms. The aim of this study is to investigate whether in patients with sCAA, cognitive impairment and...